|
|
|
|
|
|
| Date: Thursday, June 25, 2026 (10:30 AM-11:15 AM) Duration: N/A 45 Minute(s) |
||
| URL: https://aahfn2026.eventscribe.net/index.asp | ||
| Location: The Hilton San Diego, Bayfront Room: Sapphire ABEF, 1 Park Blvd San Diego, California | ||
|
AGENDA 10:30 AM Introduction Lisa Rathman, MSN, CRNP, ACNP-BC, CHFN 10:33 AM MRAs in HF: The Changing Landscape Ankeet Bhatt, MD, MBA, ScM 10:55 AM Case Presentation: Best Practices for Using Foundational Therapies and Key Messages for Patients Lisa Rathman, MSN, CRNP, ACNP-BC, CHFN 11:10 AM Question and Answer
EDUCATIONAL OBJECTIVES 1. Describe the clinical data for steroidal mineralocorticoid receptor antagonists (sMRAs) through the spectrum of ejection fraction in heart failure and their safety profiles and tolerability. 2. Explain the pharmacologic profi le/characteristics of nonsteroidal MRA (nsMRA) therapy and clinical evidence in patients with heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF). 3. Summarize information for initiation of evidence-based therapies in HFmrEF and HFpEF patients and prudent follow-up.
Educational Grant This activity is supported by an independent educational grant from Bayer.
CHAIR Lisa Rathman, MSN, CRNP, ACNP-BC, CHFN Lead Nurse Practitioner Heart Failure Section Penn Medicine Lancaster General Health Lancaster, Pennsylvania
Ankeet S. Bhatt, MD, MBA, ScM Assistant Professor Kaiser Permanente Bernard J. Tyson School of Medicine Pasadena, California |
||
|
|
||